FASEB BioAdvances
Title Abbreviation
FASEB Bioadv
Electronic ISSN
2573-9832
Readership
Academicians, Bio Chemists, Biologists, Biomedical Engineers/Technologists, Biomedical Researchers, Cytologists/Cell Biologists, Geneticists, Molecular Biologists
Scope
FASEB BioAdvances is an international open-access journal of the Federation of American Societies for Experimental Biology (FASEB). FASEB is the nation’s largest federation of U.S. biomedical societies and is dedicated to advancing the biological and biomedical sciences.
FASEB BioAdvances welcomes submissions reporting original research across the wide realm of the life sciences, across scales of complexity—from molecules, cells and organs to whole organisms, populations and ecosystems, as well as interdisciplinary biological and biomedical research interfacing with other disciplines. In addition to original research, the journal publishes methods and other novel tools/approaches of interest, negative findings that address important unresolved issues, expert reviews, and perspectives on the broader issues affecting academia, science and society. The journal invites submissions from authors around the globe and commits to providing a fair and robust peer review process, rapid handling, and the broadest dissemination of content.
Sponsoring Association(s)
Federation of the American Societies for Experimental Biology (FASEB)
Publisher Name
John Wiley & Sons, Inc. - NJ
Impact Factor
JCR Categories/Rank
Electronic Circulation
Submission to Acceptance
Acceptance to Online Publication
Rejection Rate
Frequency
Author Submission Guidelines